About
Learn about how Novartis is organized and our strategy, vision and mission. Meet our people and read about our commitments to diversity, equity and inclusion. Explore our history which goes back more than 250 years.
Patients and Caregivers
Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.
Healthcare Professionals
Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.
Research & Development
Discover how Novartis turns breakthrough science into transformative, high-value treatments. Learn about our innovation engine, the Novartis Institutes for BioMedical Research (NIBR) and explore our research areas, technology platforms and pipeline.
Environmental, Social and Governance
Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.
Investors
Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.
News
Information for journalists including media releases, statements, stories, multimedia resources and more.
Careers
Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.
Clinical Trials
Find recruiting clinical trials and learn more about how to participate or work with Novartis on clinical studies. Read about our clinical trials transparency initiatives.
Partnering
Learn about our approach to partnering which combines capabilities, collaboration and culture.
Supplier Portal
Practical information and resources for suppliers around the world.
Contacts
Get in touch.
Home
Welcome to Novartis where we are reimagining medicine to improve and extend people’s lives.
The 'Wearing Off' Effect of DMT
Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps
Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)
A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission
A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea
Pharmacokinetics and Safety Study of Siremadlin (HDM201) in Participants With Mild, Moderate and Severe Hepatic Impairment
A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China
Study of Efficacy and Safety of AIN457/Secukinumab in Patients With Rotator Cuff Tendinopathy
Study Evaluating Kesimpta® Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies
An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.